Heron Therapeutics, Inc.

NAICS
325412 Pharmaceutical Preparation ManufacturingThis U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Learn more at the U.S. Census Bureau
Name | Role | Address |
---|---|---|
CORPORATION SERVICE COMPANY | Agent | 222 JEFFERSON BOULEVARD SUITE 200, WARWICK, RI, 02888, USA |
Name | Role | Address |
---|---|---|
IRA DUARTE | CFO | 100 REGENCY FOREST DRIVE, SUITE 300 CARY, NC 27518 USA |
Name | Role | Address |
---|---|---|
ADAM MORGAN | CHAIRMAN | 100 REGENCY FOREST DRIVE, SUITE 300 CARY, NC 27518 USA |
Name | Role | Address |
---|---|---|
SHARMILA DISSANAIKE | DIRECTOR | 4242 CAMPUS POINT CT, SUITE 200 SAN DIEGO, CA 92121 USA |
SUSAN RODRIGUEZ | DIRECTOR | 4242 CAMPUS POINT CT, SUITE 200 SAN DIEGO, CA 92121 USA |
CHRISTIAN WAAGE | DIRECTOR | 4242 CAMPUS POINT CT, SUITE 200 SAN DIEGO, CA 92121 USA |
CRAIG A JOHNSON | DIRECTOR | 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO, CA 92121 USA |
MICHAEL KASETA | DIRECTOR | 100 REGENCY FOREST DRIVE, SUITE 300 CARY, NC 27518 USA |
Name | Role | Address |
---|---|---|
MELISSA JAREL | SECRETARY | 100 REGENCY FOREST DRIVE, SUITE 300 CARY, NC 27518 USA |
Name | Role | Address |
---|---|---|
CRAIG COLLARD | CEO, DIRECTOR | 100 REGENCY FOREST DRIVE, SUITE 300 CARY, NC 27518 USA |
Number | Name | File Date |
---|---|---|
202457657530 | Annual Report | 2024-07-08 |
202457238810 | Revocation Notice For Failure to File An Annual Report | 2024-06-25 |
202334771740 | Annual Report | 2023-04-30 |
202209349890 | Annual Report | 2022-02-03 |
202187033040 | Annual Report | 2021-01-18 |
This company hasn't received any reviews.
Date of last update: 02 Jun 2025
Sources: Rhode Island Department of State